Portfolio company
Integrated Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops small-molecule therapies for age-related diseases using a synthetic biology and machine learning platform to target cellular stress responses.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Gordian Biotechnology
This company develops an in vivo drug discovery platform to identify therapies for age-related diseases for the pharmaceutical and healthcare sectors.
BioAge Labs
This company develops therapeutic drugs targeting the biology of human aging to treat patients with metabolic and cardiovascular diseases.
Shift Bioscience
This biotechnology company develops cellular rejuvenation therapeutics and an AI-driven discovery platform for pharmaceutical researchers to treat age-related diseases.
Octant Bio
This company develops small molecule drugs for patients with protein misfolding diseases using high-throughput synthetic biology, generative chemistry and machine learning.
Ten63 Therapeutics
This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.
Enveda Bioscience
This company develops small molecule medicines for patients with inflammatory and metabolic diseases by using machine learning to map natural plant chemistry.
Rubedo Life Sciences
This company develops small-molecule therapeutics and anti-ageing skin care products for patients with age-related diseases and consumers seeking skin rejuvenation.
Congruence Therapeutics
This biotechnology company develops small molecule medicines for patients with metabolic, neurological, immunological and oncological diseases using machine learning and biophysics.
